Background: Hospital acquired infections continue to be an important cause of morbidity and mortality among hospitalized patients. Hospital acquired pneumonia (HAP) results in a significant increase in the cost of care of hospitalized patients. Its development prolongs a patient's stay in the Intensive Care Unit (ICU). Accurate information concerning the clinical profile of HAP is lacking in South India. This study was conducted prospectively to evaluate the clinical profile of HAP in ICU patients. Methods: This prospective study was conducted over a period of one year among 2454 patients admitted in IMCU of Coimbatore Medical College & Hospital, Tamil Nadu. The specimens' sputum, bronchoscopic alveolar lavage (BAL) and endotracheal aspirate (ETA) were collected for microbiological confirmation and processed using standard laboratory techniques. Results: Out of 2454 cases, 253 (10.3%) patients developed HAP. The incidence of HAP was higher (55.73%) in the age group more than 60 years. Out of 1352 patients on mechanical ventilation, 62.0% of patients (n=157) developed HAP. Conclusions: This study provides an insight into the incidence of HAP with the occurrence being most in the age group more than 60 years. Our study also highlights that mechanical ventilation was an important risk factor for the development of HAP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.